Related Experiment Videos
Antigen-specific proliferative human T-lymphocyte clones with specificity for Chlamydia trachomatis
Scandinavian Journal of Immunology
|October 1, 1983
Summary
Researchers cloned T-lymphocyte clones (TLC) specific for Chlamydia trachomatis antigen, finding they require shared HLA-D/DR molecules for antigen-specific proliferation. These T cells are crucial for understanding Chlamydia immunology.
Area of Science:
- Immunology
- Cell Biology
- Microbial Pathogenesis
Background:
- Chlamydia trachomatis is a significant human pathogen.
- Understanding T-cell responses is crucial for developing effective immunity and vaccines.
- T-lymphocyte clones (TLC) provide a valuable tool for dissecting antigen-specific immune responses.
Purpose of the Study:
- To generate and characterize T-lymphocyte clones (TLC) specific for Chlamydia trachomatis antigens.
- To investigate the requirements for antigen-specific proliferation of these TLC.
- To confirm the clonal nature and functional characteristics of the generated TLC.
Main Methods:
- Limiting dilution technique was used to clone T cells primed with Chlamydia trachomatis antigen.
- High proliferative responses were used to select TLC.
- Kinetic studies, OKT4 staining, antigen specificity assays, and subcloning were performed.
Main Results:
- A cloning efficiency of 20-25% was achieved.
- Selected TLC exhibited peak proliferative responses between 60-84 hours post-stimulation.
- TLC were identified as OKT4+ and demonstrated specificity for chlamydial antigen when using non-T cells as antigen-presenting cells (APC).
- Antigen-specific proliferation necessitated shared class-II HLA-D/DR determinants between TLC and APC.
- Subcloning confirmed the true clonal nature of the TLC.
Conclusions:
- Successfully generated antigen-specific T-lymphocyte clones (TLC) for Chlamydia trachomatis.
- Demonstrated the requirement for HLA-D/DR compatibility for antigen recognition by these TLC.
- These findings contribute to the understanding of T-cell mediated immunity against Chlamydia infections.